Gene Query: GNE

Dataset Description Geneva Score
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 104.15
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 58.3
Role of COP1 on MAP kinase transcriptional output in melanoma 56.86
Effect of nuclear IL-33 on gene expression 53.64
Dtx3L and Androgen Signaling in Prostate Cancer 52.6
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 39.36
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 39.02
Region-specific Innate Antiviral Responses of the Human Epididymis 38.93
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 36.29
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 36.29
Differentially expressed genes post knock down of lincDUSP26 31.53
Transcriptome analysis of kidney organoids 31.12
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 29.64
Primary human trophoblast from term placenta 28.42
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 28.06
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 25.12
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 25.01
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 23.72
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 23.72
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 22.91
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 22.86
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 21.86
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 21.61
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 21.55
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 21.37
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 21.37
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 20.81
Cleavage Factor Im as a key regulator of 3’ UTR length 20.45
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 20.17
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 19.69
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 17.92
Identifying the molecular mode of action of itraconazole in colorectal cancer 17.41
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 17.25
TGF-β promotes genomic instability after loss of RUNX3 16.99
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 16.93
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 16.62
ARS2 is a general suppressor of pervasive transcription [RNAseq] 16.3
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 15.63
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 15.62
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 15.46
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 15.4
TCF7L1 knockdown in pancreatic cancer 14.99
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 14.92
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 14.87
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 14.73
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 14.65
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 14.36
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 14.33
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 14.33
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 14.25
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 14.07
DRB/GRO-Seq -/+ UV 14.01
Transcriptional effect of ETV1 knockdown in melanoma cells 13.92
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 13.79
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 13.71
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 13.48
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 13.48
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 13.34
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 13.24
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 12.99
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 12.62
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 12.34
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 12.2
Illumina Total RNA-seq in HeLa 12.14
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 12.02
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 11.71
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 11.69
RNA-seq analyisis of PUM2 knockout cells 11.6
RNA-seq analysis and shRNA screen of breast cancer 11.48
RNA-seq analysis of breast cancer 11.48
Rorc disruption in human FG pancreatic cancer cells 11.48
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 11.46
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 11.34
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 11.32
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 11.31
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 11.18
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 11.12
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.01
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.01
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 10.98
mRNA sequencing of oropharyngeal cancer cell lines 10.92
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 10.92
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 10.77
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 10.76
Effect of PRDM11 depletion in U2932 cells 10.75
The effect of Abl kinases on non-small cell carcinoma global transcriptome 10.7
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.64
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 10.6
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 10.51
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 10.44
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 10.32
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 10.32
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 10.32
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 10.22
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 10.14
RNA-seq of YB5 cells treated with Proscillaridin A 10.0
HNF1 regulates critical functions of the human epididymis epithelium. 9.99
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 9.99
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 9.9
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 9.85
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 9.83
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 9.79
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 9.72
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 9.71
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 9.68
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 9.68
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 9.66
Overexpression and knockdown experiment for circCSNK1G3 9.63
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 9.62
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 9.51
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 9.49
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 9.49
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 9.41
snRNAs as regulators of alternative splicing 9.29
Transcriptomic and gene ontology profiling of the human corneal cell types 9.11
Expression by CD133+ cells isolated from the adult human exocrine pancreas 9.03
RNA seq comparison between scrambled and shGRP78 cells 8.83
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.82
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 8.78
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 8.62
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 8.43
RNA-seq of cancer cell lines treated with T-025 8.43
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 8.41
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 8.36
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 8.2
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.18
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 8.14
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 8.07
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 8.0
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 7.94
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 7.82
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 7.82
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 7.81
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.79
Survival of pancreatic cancer cells lacking KRAS function 7.79
U1 snRNP telescripting regulates size-function stratified human genome 7.77
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 7.67
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.67
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.67
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 7.63
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 7.58
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.45
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.35
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 7.35
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 7.35
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 7.32
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 7.24
CD73 knockdown effect in pancreatic cancer cell lines 7.17
SETBP1-WT and SETBP1-G870S epigenetic landscapes 7.13
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 7.13
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 7.1
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 7.02
A prostate cancer chromatin interaction map 6.99
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.97
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 6.94
RNA-seq of human aneuploid cell lines with Trisomy 21 6.93
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 6.89
Transcriptional changes in lymphoma cells induced by LSD1 depletion 6.89
Capturing the Interactome of Newly Transcribed RNA 6.88
Capturing the Interactome of Newly Transcribed RNA (RICK) 6.88
Genome wide expression change by RNF168 knocking down in NEC cells 6.8
Gene expression analysis of human liver progenitor-like cells in culture 6.78
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 6.76
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 6.76
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.71
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 6.67
KSDM1b Role in Ewing Sarcoma 6.67
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 6.66
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 6.63
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.63
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.52
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.49
N6-methyladenine DNA Modification in Glioblastoma 6.49
Functional role of SLIT2 and ROBO1 in trophoblasts 6.42
RNA-sequencing 6.41
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 6.39
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 6.38
Ebola virus (EBOV) infection of ARPE-19 cells 6.32
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 6.31
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 6.26
Gene expression profile in breast cancer cell lines using RNA sequencing 6.24
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 6.21
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 6.2
Age-Related Gene Expression Changes in Prostate Cancer Patients 6.2
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 6.18
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 6.18
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 6.17
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.16
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 6.14
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 6.14
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 6.13
Effect of drugs on transcriptomic profiles 6.12
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 6.12
Lysine benzoylation is a novel histone mark 6.09
Lysine benzoylation is a novel histone mark [RNA-seq] 6.09
RNA-Seq from early time points in the kidney differentiation protocol 6.09
ARID1A and ARID1B loss in HCT116 cells 6.09
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.07
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 6.03
Global transcriptome analysis of HAP1 cells 6.01
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 5.99
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 5.96
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.92
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 5.92
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 5.92
HEK293 TFAM Knockout Expression Study 5.9
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 5.89
DART-seq: an antibody-free method for global m6A detection 5.89
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 5.88
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 5.88
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 5.87
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.86
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.86
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.86
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.78
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.78
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 5.77
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 5.76
Fusion discovery in breast cancer cell line 5.71
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.66
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 5.66
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 5.66
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 5.63
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 5.61
The effect of PPARG inhibition on human angiomyolipoma cells 5.59
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 5.57
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.57
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.53
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 5.52
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 5.49
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 5.49
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 5.47
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 5.47
Fbxo32 mediated gene expression program underlies EMT and metastasis 5.4
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 5.39
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 5.36
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 5.33
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 5.33
Hepatitis C virus functionally sequesters miR-122 5.33
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 5.32
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 5.27
METTL3 promotes translation in human cancer cells 5.25
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 5.24
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 5.24
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 5.19
RNAseq Study in CC-671 Treated Cal-51 Cells 5.14
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.11
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 5.09
RNA-seq of tumor cells following angiopellosis extravasation 5.06
ETV7 and interferon response 5.02
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.02
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 5.0
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 5.0
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 5.0
Effect of from Human Umbilical Vein Endothelial Cells 4.89
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 4.87
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 4.86
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 4.79
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 4.75
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 4.74
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 4.73
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 4.73
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.69
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 4.66
Functional role of CPPED1 in trophoblasts. 4.66
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 4.65
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.65
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 4.62
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 4.6
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 4.59
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 4.59
Transcriptomic analysis of the HOTAIR-regulated genes 4.58
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 4.52
Selective suppression of endothelial cytokine production by progesterone receptor 4.52
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.52
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 4.49
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.43
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 4.42
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 4.41
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 4.39
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.3
Selective expression of long non-coding RNAs in a breast cancer cell progression model 4.29
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 4.27
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 4.25
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 4.19
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 4.18
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.16
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 4.15
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 4.14
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 4.05
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.0
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 4.0
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 3.99
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 3.99
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.98
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 3.98
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.95
Gene expression in GBM with Cav3.2 inhibition 3.93
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 3.89
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 3.84
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 3.82
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 3.79
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.76
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.74
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.66
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.64
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.64
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 3.64
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.61
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 3.61
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 3.52
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.48
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 3.45
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 3.45
Real-time observation of light-controlled transcription in living cells 3.45
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 3.44
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.44
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 3.41
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 3.39
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 3.39
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.32
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.31
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.27
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.25
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 3.22
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.21
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 3.17
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 3.1
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.04
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.02
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.02
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 2.99
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 2.99
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.98
The cohesin release factor WAPL restricts chromatin loop extension. 2.98
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.98
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 2.97
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.95
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.94
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.93
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.93
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.91
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 2.91
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 2.91
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 2.91
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.87
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 2.83
Transcriptome of EBV-infected gastric cancer cell lines 2.8
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.78
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 2.77
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 2.77
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.75
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.72
UV_24h_GRO-Seq 2.6
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 2.6
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.58
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.58
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.54
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.52
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.52
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.5
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.48
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.41
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.4
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.4
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 2.38
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.33
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 2.33
Polarized B -cell functions 2.31
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.26
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.26
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 2.25
Gene expression patterns define the hepatocyte-like cells derived by different strategies 2.24
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 2.24
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.22
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 2.21
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.21
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.2
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.14
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.07
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.06
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.05
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 2.03
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.01
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.98
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.96
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.96
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 1.93
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 1.93
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.91
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.91
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.91
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 1.88
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.86
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.85
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.85
RNAseq analysis of ruxolitinib treated breast cancers 1.77
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.72
m6A-dependent regulation of messenger RNA stability 1.71
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.71
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.67
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.67
An acquired vulnerability of drug resistant melanoma with therapeutic potential 1.67
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 1.67
RNA Seq of Alagille liver biopsies 1.66
Alagille_Nodder 1.66
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.65
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.63
Gene expression profile of human placenta from T. Cruzi infected mothers 1.63
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.57
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.51
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.49
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 1.39
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 1.38
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.37
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.36
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.36
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.36
Myc activation coordinates gene transcription and protein translation responses 1.32
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.32
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 1.31
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.17
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.16
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.14
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.12
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.1
Functional significance of the HIV-1 Tat signature amino acid residues 1.1
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.09
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.09
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 1.05
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.04
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.03
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.01
Electronic cigarettes 0.95
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 0.94
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.88
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.88
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.84
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.82
RNAseq of T-ALL upon long non coding rna purturbation 0.81
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.78
Gene expression profile in breast cancer cells 0.78
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.75
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.75
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 0.73
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 0.7
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 0.7
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.64
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.64
The role of the Calcium-Sensing receptor in colorectal cancer 0.64
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.63
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.63
Hepatocyte maturation 0.63
The gene expression profiles of gallbladder cancer 0.61
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.59
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.59
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.58
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.58
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.57
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 0.55
RNA seq analysis of human Fetal and adult derived Enterospheres 0.54
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.47
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.47
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.47
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.45
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.43
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.43
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.42
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.4
Gene expression analysis of breast cancer cell-lines 0.4
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.4
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.4
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.4
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.38
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.37
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 0.37
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.37
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.35
Human ovarian granulosa cell transcriptome 0.35
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 0.34
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.34
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.34
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.28
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.27
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.27
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 0.24
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.23
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.23
Identification of expressed and conserved human non-coding RNAs 0.19
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.19
RNA sequencing of human pancreatic cancer cell lines 0.16
Finding missing proteins from epigenetically manipulated human cells 0.15
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.13
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.12
Gene expression analysis of human adenomas. 0.09
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.08
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.08
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.06
Function and hormonal regulation of GATA3 in human first trimester placentation 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation